WS10.2 – Impact of Poor Quality and Lack of Regulatory Focus on the Clinical Supply Chain

This workshop will identify the significant risks and costs associated with inadequate quality control and regulatory oversight in clinical trial supply chains. Participants will explore real-world consequences, including delayed timelines, regulatory non-compliance, financial losses, and compromised patient safety. The session provides actionable insights and strategies to proactively and aggressively identify, address, and prevent clinical supply quality and compliance issues.